Academic History
Katja Weisel, MD, University Medical Center Hamburg-Eppendorf, is a Medical Specialist in Internal Medicine and Hematology and Oncology.
Speaking on R/R multiple myeloma
Dr Weisel is interested in the treatment of multiple myeloma, particularly relapsed and refractory multiple myeloma. She is currently conducting the study ‘Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk’.
